223 related articles for article (PubMed ID: 10464299)
1. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
[TBL] [Abstract][Full Text] [Related]
2. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
[TBL] [Abstract][Full Text] [Related]
3. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
Sotgia F; Woodman SE; Bonuccelli G; Capozza F; Minetti C; Scherer PE; Lisanti MP
Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1150-60. PubMed ID: 12839838
[TBL] [Abstract][Full Text] [Related]
5. Caveolae and caveolin-3 in muscular dystrophy.
Galbiati F; Razani B; Lisanti MP
Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
[TBL] [Abstract][Full Text] [Related]
7. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C
Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147
[TBL] [Abstract][Full Text] [Related]
11. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
[TBL] [Abstract][Full Text] [Related]
12. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
Bönnemann CG; Finkel RS
Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
[TBL] [Abstract][Full Text] [Related]
13. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
Merrick D; Stadler LK; Larner D; Smith J
Dis Model Mech; 2009; 2(7-8):374-88. PubMed ID: 19535499
[TBL] [Abstract][Full Text] [Related]
14. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
15. Two novel CAV3 gene mutations in Japanese families.
Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
[TBL] [Abstract][Full Text] [Related]
16. Molecular and muscle pathology in a series of caveolinopathy patients.
Fulizio L; Nascimbeni AC; Fanin M; Piluso G; Politano L; Nigro V; Angelini C
Hum Mutat; 2005 Jan; 25(1):82-9. PubMed ID: 15580566
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-3 in muscular dystrophy.
McNally EM; de Sá Moreira E; Duggan DJ; Bönnemann CG; Lisanti MP; Lidov HG; Vainzof M; Passos-Bueno MR; Hoffman EP; Zatz M; Kunkel LM
Hum Mol Genet; 1998 May; 7(5):871-7. PubMed ID: 9536092
[TBL] [Abstract][Full Text] [Related]
18. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms.
Bushby KM
Hum Mol Genet; 1999; 8(10):1875-82. PubMed ID: 10469840
[TBL] [Abstract][Full Text] [Related]
19. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
Sotgia F; Bonuccelli G; Minetti C; Woodman SE; Capozza F; Kemp RG; Scherer PE; Lisanti MP
Am J Pathol; 2003 Dec; 163(6):2619-34. PubMed ID: 14633633
[TBL] [Abstract][Full Text] [Related]
20. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
